8 results
Main objective: To evaluate the pain reduction in patients receiving Instanyl®Secondary objectives: To evaluate; the duration of pain reduction in patients receiving Instanyl®; the degree of adverse effects in patients receiving Instanyl®: whether…
- To evaluate the demographic, clinical and genetic characteristics of all known patients with a diagnosis of cystinuria and cystine nephrolithiasis in the Netherlands.- To evaluate the relationship between genotype and phenotype of all known…
Diagnosis of patients with primary hyperoxaluria in a cohort of patients with recurrent urolithiasis.
Primary objective:Can a difference between the change in the perception of pain over time (0-60 minutes) between tramadol and butylscopolamine in renal colic be proven?Secundary objectives:- Can a difference in the decline in VAS-score over time (0-…
The aim of this study is to demonstrate an advantage of intraoperative CT-guided evaluation to ensure that the patient is stone free. If there a still fragments visible they are removed to prevent re-interventions in the future.
The aim of this study is to demonstrate the feasibility of CBCT-based stereotactic navigation to perform a better and optimal renal access puncture, which may enable higher stone free rates. This may lower intraoperative ERD during PCNL with…
The purpose of this study is to analyse the effect on pain reduction of butylscopolamine in a continuous intravenous infusion compared to a placebo in patients with renal colics not responding to oral NSAIDs.
Primary Objective: * Study the relationship between the pre-transplant plasma oxalic acid level and the risk of oxalate deposition in for cause renal transplant biopsies within 6 months after renal transplantation. Secondary Objective(s): * Track…